"Studies Towards the Synthesis of Diaporthein B And Studies Towards the" by Ian Tingyung Hsu

Date of Award

Spring 2022

Document Type

Dissertation

Degree Name

Doctor of Philosophy (PhD)

Department

Chemistry

First Advisor

Herzon, Seth

Abstract

In the first chapter of this thesis, I describe the development of two convergent, fragment-based strategies to prepare the oxidized carbon scaffold of diaporthein B (1). Diaporthein B (1), initially isolated from the fungal genus Diaporthe, is an antimycobacterial pimarane diterpene that exhibited a minimum inhibitory concentration (MIC) of 3.1 µg⋅mL–1 against M. tuberculosis, as well as half-maximal inhibitory concentrations of 1.5–3 µM against HCT and LoVo colon cancer cell lines. The first synthetic approach towards diaporthein B (1) furnished the tricyclic carbon skeleton 154 in 9 steps from (R)-carvone through a diastereoselective 1,2-addition between two elaborated cycloalkenones, a novel carbonylative Stille cross-coupling, and a silyl migration-mediated aldol cyclization–deprotection cascade. The second route accessed the oxidized scaffold 175 in 10 steps from 3-methylanisole through a diastereoselective Mukaiyama–Michael addition of a bicyclic silyloxyfuran to a γ-hydroxy enone followed by an epoxidation–ring opening sequence.In the second chapter of this thesis, I describe the development of a modular, stereospecific approach to the C31 Trp3–Lys5 crosslink in the antibiotic darobactin A (181). Darobactin A (181) is a ribosomally synthesized and post-translationally modified peptide isolated from the nematode-symbiotic genus Photorhabdus. Modifications to the heptapeptide include an unusual C–C crosslink from the C6 indole of Trp3 to the β-carbon of Lys5 at C31, and an unprecedented aromatic–aliphatic ether crosslink from the C7 indole of Trp1 to the β-carbon of Trp3 at C17. Darobactin A (181) exhibits promising antibacterial activity, with MICs in the single-digit µg⋅mL–1 range against multidrug-resistant, Gramnegative pathogens A. baumannii, P. aeruginosa, and members of Enterobacteriaceae. I developed an 8-aminoquinoline (AQ) directed, C–H activation sequence to stereospecifically synthesize the C31 Trp3–Lys5 crosslink en route to the tripeptide 267. Finally, I describe our efforts to complete the Trp3–Ser4–Lys5 macrocycle via traditional head-to-tail amide condensations and via C–H activation.

Share

COinS